Amerique du Nord S.N.C. Sanofi-Aventis insider trades: Regeneron Pharmaceuticals (REGN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Amerique reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 13, 2010 | REGN | ↑ Buy | 1,017,401 | $28.00 | $28.5M | Indirect | Oct 14, 2010 (1d) |
| Feb 11, 2010 | CHTT | ↑ Buy | 30,641,430 | $93.50 | $2.86B | By River Acquisition Corp. | Feb 11, 2010 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other REGN insiders
Open-market trades in the last 12 months
About Amerique du Nord S.N.C. Sanofi-Aventis's insider trades
Amerique du Nord S.N.C. Sanofi-Aventis is a 10% owner of Regeneron Pharmaceuticals (REGN). Since Feb 11, 2010, Amerique has reported 2 open-market purchases worth $2.89B and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.